SITC 2021: Join us in person or virtually Join SITC in Washington, D.C., or virtually, Nov. 10-14, 2021, to take part in the leading destination for scientific exchange, education and networking in the cancer immunotherapy field. Click here for more information about attending SITC 2021.
Submit your Cutting-Edge Research
The deadline to submit research for a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application is 5 p.m. PDT on July 29, 2021.
SITC Clinical Practice Guideline Webinar – Multiple MyelomaA free, hour-long webinar on cancer immunotherapy for multiple myeloma is coming up soon. Advance your understanding with practical management pearls and case-based learning led by expert panel authors from SITC’s clinical practice guideline on June 16 at 5 p.m. ET.
SITC is pleased to announce two award opportunities that will assist early career investigators in advancing their cancer immunotherapy research by leveraging spatial technology platforms. Applications are due May 13 by 11:59 p.m. EDT.
A series of eight two-hour online seminars will feature experts in a given subject area to provide an overview of the current scientific knowledge about an area of immunotherapy. An interactive Q&A session will follow the topic overview, providing attendees the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.
Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop, Sept. 29–30, 2021, in San Diego. This SITC workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and the maximization of existing techniques. Submit your research by 5 p.m. PDT on July 22.
Attend SITC's Bispecific T cell Engagers Workshop, Sept. 30–Oct. 1, 2021, in San Diego. This SITC workshop will focus on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, the impact of the tumor microenvironment, and advances in conditionally-active binding.
Comprised of several authoritative reviews of COVID-19 and Cancer Immunotherapy, this series, edited by Paolo Antonio Ascierto, MD and Jason D. Goldman, MD, MPH, will explore basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations.
Attend SITC's Cytokines in Cancer Immunotherapy Workshop, Oct. 11–12, 2021, in New York. This SITC workshop will focus on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches. Submit your research by 5 p.m. EDT on July 22.
Now Available: SITC Clinical Practice Guideline on Immunotherapy for the Treatment of Lymphoma
Join Alan Hutson, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
New Online Patient Course Available: Understanding Cancer Immunotherapy Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in tumor immunology and cancer immunotherapy.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
Presentations from the 2019-2020 Advances in Cancer Immunotherapy™ Series – Tucson, AZ virtually held on October 31, 2020 are now available in the SITC Resource Library. Click here to access ACI – Tucson presentations. You can also reach these materials ...
Presentations from the 2019-2020 Advances in Cancer Immunotherapy™ Series – Seattle, WA virtually held on October 31, 2020 are now available in the SITC Resource Library. Click here to access ACI – Seattle presentations. You can also reach these materials ...
Presentations from the 2020-2021 Advances in Cancer Immunotherapy™ Series – New Haven, CT virtually held on October 28, 2020 are now available in the SITC Resource Library. Click here to access ACI – New Haven presentations. You can also reach these ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com